Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer - Drug Trials For Money - Paid Clinical Trials

Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer

Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer
Condition:   Ovarian Cancer
Intervention:   Drug: Follicle Stimulating Hormone Receptor T Cells
Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   Anixa Biosciences, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 8, 2022 / by / in
Comments